NCT02962999View on ClinicalTrials.gov

Effect Of Ketamine Infusion In Patients With COPD Applied One Lung Ventilation

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Chronic Obstructive Pulmonary Disease MildChronic Obstructive Pulmonary Disease ModerateChronic Obstructive Pulmonary Disease SevereLungcancerAnesthesia
Interventions
DRUG

Ketamine

After induction, patients will be received 1 mg/kg ketamine bolus, then administered 0,5 mg/kg/hour ketamine infusion intraoperatively.

DRUG

Saline

After induction, patients will be received saline bolus, then will be administered saline infusion intraoperatively.

Trial Locations (2)

01330

Cukurova University, Adana

Unknown

Cukurova University Faculty of Medicine Research Hospital, Adana

All Listed Sponsors
lead

Cukurova University

OTHER

NCT02962999 - Effect Of Ketamine Infusion In Patients With COPD Applied One Lung Ventilation | Biotech Hunter | Biotech Hunter